<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01244776</url>
  </required_header>
  <id_info>
    <org_study_id>TEC 01</org_study_id>
    <nct_id>NCT01244776</nct_id>
  </id_info>
  <brief_title>Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer</brief_title>
  <official_title>Transplantation of Acellular Corneal Matrix to Treat Corneal Ulcer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaanxi Aierfu Activtissue Engineering</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Shenzhen AiNear Cornea Engineering Company Limited</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fourth Military Medical University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Engineering Technology Center for Tissue Engineering of Xi'an</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beijing Tongren Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>West China Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henan Provincial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wuhan Union Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Shaanxi Aierfu Activtissue Engineering</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to develop a lamellar keratoplasty method for corneal ulcer using acellular
      corneal matrix (ACM) and to make an analysis among patients for its therapeutic effect.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Infections, chemical injury, and other diseases result in acute or chronic corneal ulcer,
      which may damage corneal stroma and may lead to permanent corneal scars and blindness.
      Corneal transplantation is standard method for corneal ulcer, but severe shortage of donor
      corneas limits its application. Acellular porcine corneal matrix is similar to the native
      cornea, especially with the biological property and microstructure. Recently, this matrix has
      been proved to be safe when transplanted to animal subjects and will not be rejected by the
      recipient. In animal lamellar keratoplasty experiments, acellular corneal matrix showed that
      they can integrate into the corneal wound bed and help reconstruction of the lamellar
      integrity of corneal stroma. This study will investigate its healing effect on human corneal
      ulcer. It will provide a potential corneal substitute for this disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rejection evaluation</measure>
    <time_frame>30 days following transplantation</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Corneal wound healing</measure>
    <time_frame>90 days following transplantation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Corneal Ulcer</condition>
  <arm_group>
    <arm_group_label>Acellular corneal matrix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>acellular corneal matrix</intervention_name>
    <description>Efficacy of acellular corneal matrix to restore stroma integrity and treat corneal ulcer after lamellar keratoplasty.</description>
    <arm_group_label>Acellular corneal matrix</arm_group_label>
    <other_name>ACM</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged between 18 and 75 yrs.

          -  Corneal ulcer.

          -  Informed consent.

        Exclusion Criteria:

          -  Corneal perforation.

          -  Other ocular diseases.

          -  The presence of systemic connective tissue diseases

          -  Severe allergic constitution

          -  Pregnancy

          -  The presence of chronic disease, such as significant cardiovascular illness

          -  The patients who received clinical experiments for other medicine or medical devices
             within 3 months prior to the transplantation.

          -  Any patient that is not suitable for recruitment, in the judgment of the investigator.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liuhe Zhou, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Tongren Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yongbo Lu</last_name>
    <phone>86-29-84776153</phone>
    <email>yongerbo@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Tongren Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100730</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liuhe Zhou</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 18, 2010</study_first_submitted>
  <study_first_submitted_qc>November 18, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 19, 2010</study_first_posted>
  <last_update_submitted>May 5, 2011</last_update_submitted>
  <last_update_submitted_qc>May 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>youngbo lu</name_title>
    <organization>Shaanxi Aierfu Activtissue Engineering</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Corneal Ulcer</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

